Cognition Improvement

3

Review clinical trials related to Cognition Improvement. Use filters to narrow results by trial status, phase, treatment, biological sex and sponsor.

Condition / disease
Location
Status: Recruiting

Parent-Mediated Social Cognition Intervention for Young Children With Autism Spectrum Disorder

This study evaluates the efficacy of the Companion Mind-Drawing Cooperative Game Program, a parent-mediated, home-based structured play intervention targeting social cognitive development in young children with autism spectrum disorder (ASD). Children with ASD in the intervention group will receive a structured program in which parents attend an in-person training session (approximately 2.5 hours) at the hospital, where parents are taught to administer a series of researcher-designed cooperative game paradigms at home. Parents then deliver the intervention daily for at least 30 minutes per session over a period of six months. Monthly online video reviews by a clinician provide parents with individualized feedback and guidance to ensure program fidelity and quality. Children with ASD in the comparison group will continue to receive usual care and will not receive the program during the study period. Social cognitive outcomes - including emotion recognition, theory of mind, empathy, joint attention, self-perception, and social communication - will be assessed at baseline and at 12-month follow-up using behavioral experimental tasks and eye-tracking paradigms. This study aims to provide evidence for the efficacy of a scalable, family-implemented social cognition intervention for young children with ASD.

Participants needed: 60
Trial details
Age: 4-8Biological sex: AllType: InterventionalSponsor: Children's Hospital of Fudan UniversityUpdated: Jul 16, 2026Locations: 1
Eligibility criteria

Aged 2.5 to 14 years at time of enrollment, with a primary recruitment focus on... [+10]

Known diagnosis of a genetic syndrome associated with ASD or intellectual disabi... [+7]

Status: Not yet recruiting

A Validation Study of the Neuro-cognitive Emotion Monitoring-Intervention (NEMO-I) Application in Adolescents

This study aims to evaluate the validity and effectiveness of NEMO-I (Neuro-cognitive Emotion Monitoring-Intervention), a mobile application designed to help adolescents monitor and manage their cognitive and emotional functioning in everyday settings. NEMO-I delivers evidence-based psychological techniques-such as mindfulness, self-regulation training, and emotion monitoring-in a gamified format consisting of seven brief activities that users can complete at home in about 10 minutes each. A total of 140 middle and high school students will participate. Participants will complete standardized neuropsychological and psychological assessments before and after the intervention period. During the 21-day intervention period, participants will use the NEMO-I application at home each day at their convenience (a minimum of 10 minutes per day is recommended). By comparing pre- and post-intervention assessment results, this study seeks to determine whether the application produces meaningful benefits for adolescent mental health and to establish its suitability as a digital mental health tool.

Participants needed: 140
Trial details
Age: 12-18Biological sex: AllType: InterventionalSponsor: Seoul Women's UniversityUpdated: Jul 14, 2026Locations: 1
Eligibility criteria

Middle or high school students currently enrolled in school [+2]

Borderline intellectual functioning or intellectual disability (IQ below 80) [+2]

Status: Not yet recruiting

Westlake Aging Cohort (WeAC)

The Westlake Ageing Cohort (WeAC) is a longitudinal cohort study conducted in Hangzhou, Zhejiang Province, China. The investigators aim to enroll 2,800 participants aged 55 years and older for long-term follow-up. The population will include individuals with neurodegenerative diseases or those at the prodromal stage of cognitive impairment, as well as healthy middle-aged and older adults serving as controls. The investigators will collect their sociodemographic, dietary, lifestyle, clinical, and neuroimaging data, as well as biological samples.

Participants needed: 2,800
Trial details
Age: 55-90Biological sex: AllType: ObservationalSponsor: Westlake UniversityUpdated: Jan 28, 2026Locations: 2
Eligibility criteria

Age between 55 and 90 years (inclusive) at baseline. [+5]

Participants with major medical or neuropsychiatric conditions unrelated to the... [+3]